Driehaus Micro Cap Growth Fund DMCRX

Morningstar Medalist Rating
  • NAV / 1-Day Return $17.26  /  −1.99 %
  • Fund Size $499.2M
  • Adjusted Expense Ratio 1.340%
  • Net Expense Ratio 1.300%
  • Fee Level: Distribution High
  • Share Class Type No Load
  • Morningstar Category Small Growth
  • Equity Style Box (Funds) Small Growth
  • Minimum Initial Investment $10,000
  • Investment Status Limited
  • TTM Yield 0.22%
  • Turnover Ratio 142%

Morningstar’s Analysis DMCRX

Will DMCRX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Driehaus Micro Cap Growth holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DMCRX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 17.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Praxis Precision Medicines Inc Ordinary Shares

2.28 12M
Healthcare

Definium Therapeutics Inc Ordinary Shares

2.27 12M
Healthcare

Spyre Therapeutics Inc

2.04 11M
Healthcare

Bandwidth Inc Class A

1.89 10M
Technology

Amylyx Pharmaceuticals Inc

1.75 9M
Healthcare

Kiniksa Pharmaceuticals International PLC Class A

1.65 9M
Healthcare

Xometry Inc Ordinary Shares - Class A

1.58 9M
Industrials

Immunome Inc Ordinary Shares

1.55 8M
Healthcare

Adaptive Biotechnologies Corp

1.47 8M
Healthcare

Edgewise Therapeutics Inc

1.44 8M
Healthcare

Sponsor Center